FDA meeting next week on CRL next steps…











































January is most likely, but that's after the three oral JAK and the one topical one.

My offices keep talking about ruxo cream, marketing doesnt want to hear it. I know its not a biologic, but derms like it and its going to be for moderate patients which is like 80% of our target.

Rumor from my guys is that a JAK or two might not get a boxed warning too....